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, recombination activating gene (RAG-1), and
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 mature B cells. This order, for the first time established for human B lineage
cells, shows striking similarities with that established for mouse B lineage cells in bone marrow.
 
T
 
he differential expression of genes as proteins on the
surface and inside of B lymphocyte precursors has al-
lowed a definition and separation of subpopulations of
bone marrow cells on their way to mature, antigen-reactive
B cells. In the mouse, these markers include the tyrosine
kinase c-
 
kit
 
 (CD117), the 
 
a
 
 chain of the IL-2 receptor
(CD25), CD19, B220 (CD45), leukosialin (CD43), BP-1,
components of the rearrangement machinery, i.e., terminal
deoxynucleotidyl transferase (TdT)
 
1
 
, recombination acti-
vating gene (RAG)-1 and RAG-2, 
 
m
 
 heavy (H) chains and
light (L) chains, and the components of the surrogate L
chain, V
 
preB
 
 and 
 
l
 
5
 
 (1–6). In humans, markers include
CD10, CD19, CD34, TdT, RAG-1 and RAG-2, the 
 
m
 
H
and L chains, as well as the surrogate L chains, (7–12).
In mice and humans, the surrogate L chain has been
found on the surface of two distinct early precursor popula-
tions. On the earlier cell, the surrogate L chain is associated
with a complex of glycoproteins; on the later cells, together
with 
 
m
 
H chains, it forms the pre-B receptors (11–16). In
this paper, we show that a new mAb specific for human
V
 
preB
 
 (16) detects these two early precursor B cell popula-
tions in human bone marrow.
Single-cell PCR analyses of the status of rearrangements
in both alleles of the IgH and L chain gene loci have previ-
ously allowed to order the different B lineage subpopula-
tions of mouse bone marrow in their developmental path-
way (17). In this paper, we use the same technique to
analyze the configurations of the IgH and L chain alleles in
single cells of human B lineage subpopulations. This allows
us for the first time to order these human precursors in
their developmental pathway in bone marrow.
 
Materials and Methods
 
Cells
 
Human heparinized bone marrow was obtained by iliac crest
aspiration from 53 individuals of different ages (between 9-mo
and 76-yr old), healthy or free of hematological diseases, accord-
ing to institutional guidelines established by the ethical commit-
tees at Kantonsspital and Kinderspital in Basel, Switzerland.
Bone marrow cells were isolated by Ficoll-Hypaque gradient
(density 
 
5
 
 1.077 g/ml) (Pharmacia, Uppsala, Sweden).
Dendritic cells were separated and cultured as described previ-
ously (18, 19).
 
1
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ement; L, light; RAG, recombination activating gene; RT, reverse tran-
scription; s, surface; Tdt, terminal deoxynucleotidy transferase.
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Antibodies, Immunofluorescence, and Flow
Cytometric Analysis
 
mAbs.
 
Surface staining of bone marrow cells was performed
using the following antibodies: FITC-labeled anti-CD3 and anti-
CD4; biotin (BIO)-labeled anti-CD8; FITC-labeled anti-CD10
(CALLA), anti-CD13, anti-CD14, and anti-CD16; FITC-, PE-
or BIO-labeled anti-CD19; FITC- or PE-labeled anti-CD34;
FITC-labeled anti-CD56 and anti-CD57 (Becton Dickinson &
Co., Mountain View, CA); BIO-labeled anti-CD40 (Caltag Lab-
oratories, San Francisco, CA); FITC-labeled anti-CD33 (Dako-
patts, Glostrup, Denmark); FITC-labeled anti-TdT (Immuno-
tech, Marseille, France); and nonconjugated anti-V
 
preB
 
 (mouse
IgM; SL688; 16).
 
Polyclonal Antibodies.
 
Polyclonal FITC-conjugated rabbit anti–
human IgM F(ab)
 
2
 
 and polyclonal PE-conjugated rabbit anti–human
 
k
 
L and anti-
 
l
 
L F(ab)
 
2
 
 were purchased from Dakopatts (Glostrup,
Denmark).
Polyclonal FITC-labeled goat anti–human 
 
k
 
L and anti-
 
l
 
L
were purchased from Tago Diagnostics, Inc. (Burlingame, CA).
Polyclonal PE- and BIO-conjugated goat anti–human IgM,
polyclonal BIO-conjugated goat anti–human IgD, and polyclonal
FITC- and PE-labeled goat anti–mouse IgM were obtained from
Southern Biotechnology Associates, Inc. (Birmingham, AL).
 
Streptavidin.
 
Streptavidin-PE was purchased from Southern
Biotechnology Associates. Streptavidin TRICOLOR was ob-
tained from Caltag Laboratories.
 
Cell Surface Staining and Cell Sort
 
Three-color immunofluorescence analysis and sort were used
for identification of the different B cell precursor populations.
Cell-surface immunofluorescence, flow cytometric analysis, and
cell sort were performed as described on a FACStar Plus
 
Ò
 
 or
FACSVantage
 
Ò
 
 (Becton and Dickinson) at 4
 
8
 
C (20) within 4–8 h
from aspiration of the material (21). Only cells exhibiting low
forward angle and low right angle light scattering properties (lym-
phoid gate) were analyzed and, when needed, sorted. All the
shown percentages refer to the total cells within this gate. To
identify pre-B I precursors, bone marrow cells were stained with
BIO-labeled anti-CD19 or anti-CD10 (and streptavidin TRI-
 
Table 1 
 
a. Oligonucleotides Used for PCR Analysis of Germline IgH and Igk Loci and Rearranged DH, Igk, and k2de Genes
Sequence Specificity
PCR round usage
First Second
59 primers
GTTTCTGTGCCCCTGGCTCAG Germline IgH 11
GGATTTTGTGGGGGCT(C/T)GTGTCACTG DH-primer 1* 12
ATTTTGTGGGGGCT(C/T)GTGTCACTGTG DH-primer 1* 21
GGTTTGG(A/G)(A/G)TGAGGTCTGTGTCACTG DH-primer 2‡ 12
TTTGGRRTGAGGTCTGTGTCACTGTG DH-primer 2‡ 21
GTTTTTGGCTGAGCTGAGAACCACTG DH-primer 3§ 12
TTTTGGCTGAGCTGAGAACCACTGTG DH-primer 3§ 21
GCTCGAAAAGGGAGTTGAGCTTCAGC Germline Igk1 1
AGTGGATCTGGGACAGA(C/T)TTCACTCTC Vk I/III 12
TGGATCTGGGACAGA(C/T)TTCACTCTCAC Vk I/III 21
TCTAACCGGGACTC(C/T)GGGGTCCC(A/T)GAC Vk II/IV 12
GGGTCCC(A/T)GAC(A/C)GATTCAG(C/T)GGCAG Vk II/IV 21
TGAGTGGCTTTGGTGGCCATGCCAC J-Ck intron 11
3 9 primers
TCCCAGTTCCCAAAGAAAGGCC JH3 12
TACCTGAAGAGACGGTGACCATTGT JH3i 21
AACCGCAATGGCGCAGGAAACC JH6 12
ACCTGAGGAGACGGTGACCGTGGT JH6i 21
ACCTGAGGAGACGGTGACCGTGGT JH6i 21
CACCCAAAGCCACTGACTCTGGGAG k-de 12
AGGCCACAAACCCAGCAAAGCACC k-de 21
CTGGCCATCAGCCCCAAATTTCAGAAG Jk5 12
TTAATCTCCAGTCGTGTCCCT Jk5 21
* Complementary to the sequence of DLR1, DLR2, DLR3, DLR4, and DLR5 genes.
‡Complementary to the sequence of DLR6, DXP1, DXP91, DXP4, D22/12, D21/7, D23/7, D21/9, D21/10, and D21/0.5 genes.
§Complementary to the sequence of the DQ53 gene.
iAs described in reference 22.2219 Ghia et al.
COLOR) and PE-labeled anti-CD34 antibodies. These cells
could be sorted to be stained intracellularly (see below) with ei-
ther FITC-labeled anti–human IgM or FITC-labeled anti-TdT
antibodies after fixation and permeabilization. To evaluate VpreB
expression on the surface of these cells, bone marrow samples
were stained with BIO-labeled anti-CD19 or anti-CD10, FITC-
labeled anti-CD34, and purified anti-VpreB, followed by incuba-
tion with streptavidin TRICOLOR and PE-labeled anti–mouse
IgM. Using this procedure for staining, we were also able to sort
CD342VpreB
1 cells and evaluate, in this population (pre-B II,
VpreB
1), the cytoplasmic expression of mH chain or nuclear ex-
pression of TdT, as well as the surface expression of kL or lL
chains.
Furthermore, to identify large and small pre-B II VpreB
2 popu-
lations, bone marrow samples were stained with BIO-labeled
anti-CD19 or anti-CD10, purified anti-VpreB, and FITC-labeled
anti-kL and -lL chains (followed by streptavidin TRICOLOR
and PE-labeled anti–mouse IgM). These cells were also discrimi-
nated by size on the side forward scatter profile. The two popula-
tions could be restained intracellularly for cytoplasmic mH chain
and TdT expression (see Fig. 1).
Immature B cells could be discriminated by staining with
FITC-labeled anti-CD10, PE-labeled anti-kL and lL-chains, and
BIO-labeled anti-IgD, followed by incubation with streptavidin
TRICOLOR. Single cells were sorted using the FACStar PlusÒ
equipped with an automatic cell deposition unit, directed into
polycarbonat 96-well plates (Biozym Diagnostik GmbH, Olden-
dorf, Germany) containing 10 ml of PCR buffer (three times
concentrated) or 5 ml of PBS. The plates were immediately fro-
zen on dry ice and then stored at 2708C until use.
DNA and cDNA Preparation
To prepare DNA (17), 2 ml of proteinase K (5 mg/ml; Boeh-
ringer Mannheim GmbH, Mannheim, Germany) were added to
the plates containing PCR buffer. Samples were then overlaid
with PCR oil (Fluka, Buchs, Switzerland) and incubated for 1 h
at 558C. Proteinase K was subsequently inactivated for 10 min at
958C. The plates were then stored at 2208C.
To prepare cDNA, single cells in PBS were heated up to 658C
for 2 min, and reverse transcription (RT) mix was added and in-
cubated at 378C for 1 h (Ten Boekel, E., F. Melchers, and A.
Rolink, manuscript in preparation). The enzyme was inactivated
for 2 min at 958C.
Between 24 and 40 cells of each sorted population from three
different bone marrows, from donors who were 9 mo to 13 yr
old, were analyzed as follows.
PCR Analysis
PCR amplification of DH segments, Igk gene and k-deleting
element (k-de) rearrangements was carried out in two rounds, us-
ing degenerate oligonucleotide primers (as listed in Table 1 a) to
detect as many complementary sequences as possible. Nested
primers (59 and/or 39 end) were used when needed, as shown in
Table l a. The primers used to detect DH-JH rearrangements were
designed to be complementary with the D element upstream of
heptamer-nonamer sequences of the genes available on DNA se-
quence databases, since not all the DH genes are known. Hence,
they were complementary to the members of 3 (DLR, DXP, and
DQ52) of the 7 known families within the major DH gene locus, and
they are expected to detect 10 of the 18 published sequences (22).
They were also complementary to all the known DH genes within
the minor locus (23). In detail, D primer 1 is complementary to
DLR1, DLR2, DLR3, DLR4, and DLR5 genes. D primer 2 is
complementary to DLR5, DLR6, DXP1, DXP91, DXP4, D22/
12, D21/7, D23/7, D21/9, D21/10, and D21/0.5 genes. D
primer 3 is complementary to the DQ52 gene sequence. With
these primers, two thirds of the published sequences can be ex-
pected to be detectable.
The four primers for the Vk genes (Table 1 a) were designed
according to the consensus sequence derived from the alignments
of the Vk sequences of the 32 potentially functional genes and of
the 16 genes with only minor defects (24). Within the two sets of
primers, one was complementary to the sequences of the genes
belonging to VkI and III families, in the sense that the primer had
a complete concordance in sequence for 14 genes, only a 1-bp
difference for 12 and a 2-bp difference for another 5 genes. The
Table 1 b. Olgonucleotides Used for RT-PCR Assay
Sequence Specificity
PCR round usage
First Second
59 primers
GTGGCGTTGCTGCTGCTGCTCT B29 11
CCAAATTGCAGACATCTCAAC RAG-1 11
GCCGTCAGTGTGCTGGTTAAAGAGG TdT 11
ATGTCCTGGGCTCCTGTCCT VpreB 11
3 9  primer
GCTGTGCCAAGGTGCTGAATCC B29 11
CAACATCTGCCTTCACATCGATCC RAG-1 12
ACCATCCACAGGACCATGGACTGG RAG-1 21
TCTGCTTTGAGGAATATCCTCTTGG TdT 12
AGAATCATCTTCCGCTCATGTGTGG TdT 21
TGCAGTGGGTTCCATTTCTTCC VpreB 12
GTAATACATAGCCTCGTCCTCAGG VpreB 212220 Immunoglobulin Gene Configurations in Human Lymphocyte B Precursors
other set of primers was complementary to the genes in VkII and
IV families, again in the sense that the sequence had a complete
homology with six genes, only 2 bp difference with 6 and 4 bp
difference (all in the 59 region of the primer) with only three
genes. No primers to detect families V, VI, and VII were de-
signed since they are all nonfunctional. With such primers, at least
90% of the Vk genes that are potentially functional or have only
minor sequence defects can be expected to be detectable.
The PCR amplification conditions were as described by Ten
Boekel et al. (17). PCR amplification of cDNA samples was car-
ried out using the primers listed in Table 1 b with the same strat-
egy described above. The lengths of the different RTPCR prod-
ucts of the DNA and RNA analyses are listed in Table 2, a and b,
respectively. All the primer pairs are spanning intron sequences,
allowing the distinction between expressed RNA from genomic
DNA. Moreover, the primers used to detect B29 cDNA were
also able to detect a splicing variant that lacks the entire exon III
of the gene (25).
PCR Product Sequencing
The PCR products, obtained with VpreB-specific primers, were
sequenced using the Ready Reaction Dye Determinator (Perkin-
Elmer Corp.,Norwalk, CT) and an automated DNA sequencer
(model 373; Applied Biosystems, Inc., Foster City, CA).
Intracellular Staining for FACSÒ Analysis
Cytoplasmic Staining. For testing cytoplasmic mH protein ex-
pression, cells were fixed for 10 min in ice-cold 4% paraformalde-
hyde (dissolved in PBS; Fluka Chemie AG, Buchs, Switzerland)
and then permeabilized with 0.2% Tween 20 (dissolved in PBS;
Fluka Chemie) for 20 min at 378C.
Table 2 a. Approximate PCR Product Lengths of IgH and L Chain Analyses
Rearrangements Product lengths
Germline IgH 903
DH-primer 1- JH3 924 (D1, D2, D4, D5) 921 (D3)
DH-primer 1- JH3 714 (D1, D2, D4, D5) 711 (D3)
DH-primer 1- JH3 106 (D1, D2, D4, D5) 103 (D3)
DH-primer 1- JH6 1,152 (D1, D2, D4, D5) 1,149 (D3)
DH-primer 1- JH6 713 (D1, D2, D4, D5) 710 (D3)
DH-primer 1- JH6 120 (D1, D2, D4, D5) 117 (D3)
DH-primer 2- JH3 924 (DXP, D22, D23, D21/0.5) 923 (D21/9, 7)930 (D21/10)
DH-primer 2- JH3 714 (DXP, D22, D23, D21/0.5) 713 (D21/9, 7)720 (D21/10)
DH-primer 2- JH3 106 (DXP, D22, D23, D21/0.5) 105 (D21/9, 7)112(D21/10)
DH-primer 2- JH6 1,152 (DXP, D22, D23, D21/0.5) 1,151 (D21/9, 7)1,158 (D21/10)
DH-primer 2- JH6 713 (DXP, D22, D23, D21/0.5) 712 (D21/9, 7)719 (D21/10)
DH-primer 2- JH6 120 (DXP, D22, D23, D21/0.5) 119 (D21/9, 7)126 (D21/10)
DH-primer 3- JH3 904
DH-primer 3- JH3 694
DH-primer 3- JH38 6
D H -primer 3- JH6 1,132
DH-primer 3- JH6 693
DH-primer 3- JH6 100
Germline Igk 1,477
Vk I/III - Jk1 1,436
Vk I/III - Jk2 1,076
Vk I/III - Jk3 774
Vk I/III - Jk4 441
Vk I/III - Jk5 125
Vk II/IV - Jk1 1,461
Vk II/IV - Jk2 1,101
Vk II/IV - Jk3 799
Vk II/IV - Jk4 466
Vk II/IV - Jk5 150
J-Ck introl - kde 500
Vk I/III - kde 481
Vk II/IV - kde 5202221 Ghia et al.
Subsequent staining and washing procedures, as well as FACSÒ
analyses, were performed in the same way as described for surface
staining of cells, using polyclonal FITC-conjugated rabbit anti–
human IgM F(ab)2 (Dakopatts).
Nuclear Staining. After performing the surface staining, as de-
scribed before, the samples could be analyzed for the expression
of the nuclear enzyme TdT (26).
The cells were fixed in 1 ml of an ice-cold solution containing
1% paraformaldehyde (dissolved in PBS), and were incubated for
2 min on ice. They were then permeabilized in a 1.5-vol of ice-
cold absolute methanol and incubated for 20 min on ice. After
washing, cells were resuspended in an appropriate volume of FCS
(as a blocking serum) for 15 min, and a mixture of three FITC-
conjugated, anti-TdT mAbs (Immunotech) was added at a final
concentration of 1:20 for 30 min on ice. FACSÒ analysis was per-
formed as described before.
Cell Cycle Analysis
Sorted bone marrow cells were fixed in 70% ethanol at 48C
overnight. Fixed cells were resuspended in RNAse A (0.5 mg/ml;
Boehringer Mannheim), and were incubated for 30 min, at 378C.
1 mg/ml pepsin was then added and incubated for 15 min at 378C to
prepare nuclei. Finally, ethidium bromide (0.02 mg/ml in 0.2 M
Tris, pH 8–8.5, and 0.5% BSA) was added, mixed, and the nuclei
were incubated for another 15 min at room temperature. DNA
content was analyzed using a FACScanÒ instrument equipped with
the Doublet Discriminator Module.
Results
Detection of VpreB Protein on Bone Marrow Cells
with the mAb 688
Cells from human bone marrow (from 24 donors, 10-mo
to 76-yr old) were examined for the expression of VpreB
protein, by surface staining with mAb 688 in three-color
FACSÒ analysis initially for VpreB, CD10, and kL/lL chains.
After removal of the surface kL/lL1 cells and a gating for
lymphoid cells, cells were stained with CD34-specific anti-
body, and then sorted as shown in Fig. 1. CD19 expression
could be used instead of CD10 expression to achieve this
separation and enrichment of precursor B cells, since CD101
are also CD191 (not shown). Hence, from now on, we call
all CD101 precursors CD191CD101 cells.
The separation shown in Fig. 1 demonstrates that the
majority (around two out of three) of VpreB
1 CD101 B lin-
eage cells did express CD34 on their surface (Fig. 1, R2).
These triple-positive cells also expressed TdT, but not cy-
toplasmic mH chains (Fig. 1, R4). Note in the legend of the
figure that a separate staining and sorting had to be per-
formed for the R4 analysis.
An analysis by forward and side scatter gating revealed
that the R4 population was composed of a mixture of small
and large cells. Cell cycle analysis showed that z40% of
them were in S and G2/M phases (Fig. 1, R4).
A small part of the CD101VpreB
1Ig kL chain2 lL chain2
cells did not express CD34 on their surface (Fig. 1, R2).
These cells expressed mH chain, which is easily detectable
in the cytoplasm. They did not express TdT (Fig. 1, R5).
This cell population represents z5% of all CD101 B lin-
eage cells in the bone marrow. The vast majority of them,
by forward scatter profile, were found to be large. More
than 60% of these cells were in S and G2/M phases of the
cell cycle (Fig. 1, R5).
With the remaining CD101CD342 cells, in marrow that
represented 45–60% of all of the CD101 B lineage cells,
VpreB could not be detected on the surface (Fig. 1, R3).
This population consisted of 15–20% large and 80–85%
small cells; while 70–90% of the large cells were in S and
G2/M phases, only 3–5% of the small cells were in these
phases of the cell cycle, i.e., resting.
VpreB could also not be detected on the surface of CD101
CD342 sIgM1 kL chain1 or lL chain1 cells, nor on CD102
IgM1, IgD1 (kL chain1 or lL chain1) cells. The former
population consisting of immature B cells represents 20–25%
of the CD101 B lineage cells in bone marrow. Less than
2% were in S and G2/M phases, i.e., practically all of them
were resting cells. No CD31, CD41, CD81, CD131,
CD141, CD161, CD331, CD561, or CD571 cells showed
detectable expression of VpreB on their surface (all data not
shown).
We conclude that mAb 688, specific for VpreB, detects
VpreB molecules on the surface of all CD341 and a small
fraction of CD342 cells that also expresses CD19 and
CD10, but not surface (sIgM). These two precursor popu-
lations, the first TdT1 and the second TdT2, are analyzed
in more detail below.
Age-related Changes in the Number of B Lineage Precursor 
Cells in Human Bone Marrow
The representative of the CD191CD101 B lineage sub-
populations of human bone marrow described above was
analyzed in 53 donors who were 10 mo to 76 yr old. The
results are presented in Fig. 2 a as the percentage values of
cells within the lymphoid compartments, and as the per-
centage values of cells among the CD191CD101 B lineage
precursor compartments in bone marrow.
It is evident that the frequency of CD191CD101 B lin-
eage cells and the frequency of cells in all identified B pre-
cursor compartments, hence also of the VpreB-expressing B
lineage precursors, decrease with age. They are highest in
young donors who are up to the age of 10 yr old. It ap-
pears, however, that the proportions of different B lineage
precursors relative to each other remain the same through-
out life.
The frequencies of CD191CD102sIgM1 mature B cells
also decrease within the lymphoid compartment (Fig. 2 b).
Table 2 b. Approximate RT-PCR Product Lengths
RT-PCR products of RNA of: Product lengths
bp
B29 409 and 97
RAG-1 468
TdT 482
VpreB 4282222 Immunoglobulin Gene Configurations in Human Lymphocyte B Precursors
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Their relative contribution to all CD191 B lineage cells in
bone marrow, however, increase with age.
RNA Expression of the VpreB, TdT, and RAG-1 Genes
in Single Cells of Different B Lineage cells in Human
Bone Marrow
Single cells from the subpopulations of CD191CD101
CD341VpreB
1, CD191CD101CD342VpreB
1, the large cy-
cling CD191CD101CD342sIgM2, the small resting CD191
CD101CD342VpreB
2sIgM2 B lineage cells of bone marrow
from three young donors were separated by FACSÒ, and
were analyzed by RT-PCR developed for human VpreB,
TdT, and RAG-1. As a control for cDNA integrity, B29
cDNA was amplified (Table 2 b). The results of these ex-
periments are summarized in Table 3.
TdT-specific RNA expression followed the pattern of
protein expression that was detected in the earlier experi-
ments (see Fig. 1). It was only expressed in the large major-
ity of all CD341 B lineage cells.
VpreB expression on the RNA level did not completely
follow the pattern of expression of the VpreB protein. Hence,
while CD341 and some of the large cycling CD342 B lin-
eage cells expressed the protein, and while the rest of the
large and all the small resting CD342 cells did not, RNA
was not only expressed in the two subpopulations with
VpreB protein, but was expressed in the majority of CD342
large cells, as well as in up to 25% of all the small CD342
CD101 pre-B cells. The VpreB-specific mRNA expressed in
these cells was reverse transcribed, sequenced, and found to
contain the expected VpreB characteristic sequences. It re-
Figure 2. (a) Frequencies of CD191 CD101 B lineage cells and their subpopulations among total lymphoid cell compartment in human bone marrow
of donors of different ages (one donor 5 one symbol). The frequencies of these subpopulations among all CD191 CD101 cells are also given. (b) Fre-
quencies of CD191CD102sIgM1 mature B cells in the lymphoid compartments of human bone marrow, and their relative contribution to all CD191
cells in human bone marrow of donors of different ages.2224 Immunoglobulin Gene Configurations in Human Lymphocyte B Precursors
mains to be determined whether the VpreB RNA in the
VpreB protein–negative cells is functional mRNA.
RAG-1 expression was detectable in most of the CD341
B-lineage precursors, was suppressed in the majority of
CD342 large cells, and was again detectable in half of the
small CD342 cells. This modulated expression of RAG-1
RNA will be discussed below. We have shown previously
that RAG-1 mRNA is expressed in immature CD342
CD101 sIgM1 B cells, while it is not expressed in CD342
CD102 sIgM1 mature B cells (21).
PCR Analysis of DHJH and VkJk Rearrangements in
Single CD191CD101 B Lineage Cells of Different Bone 
Marrow Subpopulations
For the amplification of DHJH-rearranged IgH sequences
of VkJk-rearranged (k-de) L chain gene loci, several primers
were designed (see Materials and Methods and Table l a).
Practically the whole human kL chain gene locus is known,
and that includes orphan gene segments (24). Genes in Vk
families I, II, III, and IV are expected to contain members
that encode L chain proteins, while those in families V, VI,
and VII are all nonfunctional. The VkJk primer sets used in
our studies are expected to detect at least 90% of the 32 po-
tentially functional Vk genes, as well as the 16 nonfunc-
tional genes with minor sequence defects.
In contrast to the kL chain locus, the DH segments of the
IgH chain locus are not yet completely known. A major
locus of seven families have been detected within the IgH
chain locus on chromosome 14 (22), while another six
have been described on a minor locus on the same chro-
mosome (23). With the primer sets shown in Table 1 a, we
expect to detect approximately two thirds of these DH seg-
ments in DHJH-rearranged configurations.
Eventual sequencing of many of the PCR products de-
tected from single cells will be able to evaluate the validity
of these expectations.
The results of the PCR analyses are discussed below:
DHJH Rearrangements. A total of 36 single CD191CD101
CD341 B cell precursors from three individuals were ana-
lyzed for their status of DHJH rearrangements within the
IgH locus. The results, shown in Table 4, show that the
majority of these cells have at least one of their IgH alleles
in DHJH-rearranged conformation (see also legend to Table
4). In many cells, both alleles should be rearranged, since in
most cases, no germline H chain locus was detectable in the
PCR analyses. It remains to be analyzed how many of the
rearranged H chain loci are VHDHJH rather than DHJH rear-
ranged. If they were VHDHJH rearranged, the observed lack
of mH chain expression in this cell population would make
it likely that they would be nonproductively rearranged.
We conclude that the majority of CD191CD101CD341
B lineage precursors appear to have their IgH chain alleles
no longer in germline configuration, since many of them
have at least one allele DHJH rearranged.
The vast majority of the CD191CD101CD342 cells ex-
press mH chains in their cytoplasm (Fig. 2). Hence, they
are expected to be productively VHDJH rearranged on at
least one allele. Therefore, we did not analyze their IgH
gene loci by PCR.
Our results confirm previous suggestions of the order of
human B cell subpopulations during development in bone
marrow. The analyses of the conformations of the IgH
gene loci show that CD191CD101CD341TdT1 cells are
DHJH-rearranged precursors of the CD191CD101CD342
TdT2 cells.
VkJk Rearrangements. CD191CD101 B lineage cells of
bone marrow were separated by FACSÒ into single cells of
Table 3. RT-PCR Analyses of RAG-1, TdT, and VpreB mRNA Expression in Single Cells of the CD101CD191sIgM2 Subpopulations of 
B Lineage Precursors in the Bone Marrow of Three Donors*
B lineage precursors CD341VpreB
1 CD342VpreB
1
Large CD342
VpreB
2
Small CD342
VpreB
2
Donor a (Male, 13-yr old)
RAG-1 88% (21/24) 0% (0/23) 14% (4/24) 44% (10/23)
TdT 83% (20/24) 17% (4/23) 0% (0/24) 0% (0/23)
VpreB 75% (18/24) 87% (20/23) 80% (19/24) 17% (4/23)
Donor b (female, 3-yr old)
RAG-1 71% (17/24) 9% (2/21) 8% (2/24) 25% (6/24)
TdT 92% (22/24) 9% (2/21) 0% (0/24) 4% (1/24)
VpreB 88% (21/24) 60% (12/21) 17% (4/24) 25% (6/24)
Donor c (female, 9-mo old)
RAG-1 78% (25/32) 0% (0/28) 8% (2/24) 49% (19/39)
TdT 100% (32/32) 0% (0/28) 8% (2/24) 7% (3/39)
VpreB 71% (23/32) 93% (12/28) 50% (12/24) 33% (13/39)
*Cells were separated as described in Fig. 1. Donors are the same as those analyzed in Table 4.2225 Ghia et al.
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the subpopulations of CD341VpreB
1, CD342VpreB
1, large
CD342VpreB
2, small CD342VpreB
2, sIgM1 immature, sIgM1
sIgD1, and sIg1 kL1 or lL1 mature cells. Ig kL chain gene
loci of between 20 and 25 single cells of the different pop-
ulations from the bone marrow of two donors were ana-
lyzed for their conformations (Table 4 b).
It is evident that the vast majority of the DHJH-rear-
ranged CD191CD101CD341 precursors have their kL
chain loci in germline configuration. kL chain gene rear-
rangements are detectable in a large part of all cells, i.e., in
at least 60% of all CD342 small cells, and from there on, as
expected, in 80–95% of all immature and mature sIg1 B cells.
Interestingly, lL1 sIg1 B cells appear to have less kL chain
gene loci in germline configuration, and have more of
them deleted.
We conclude from these analyses that the majority of all
kL chain gene rearrangements occur at the transition from
VpreB
2 large CD342 to VpreB
2 small CD342 cells. Hence,
the largest subpopulation of B lineage cells in the human bone
marrow, the CD191 CD101CD342VpreB
2TdT2 RAG-l1,
cyto-plasmic mH chain1, small, resting sIg2 precursor B
cell has, to a large part, its Ig kL chain gene loci in VkJk-
rearranged conformation, but does not yet express them as
proteins so that the cells would become sIg1. Collectively,
these PCR analyses allow us to order CD191 CD101 B
lineage subpopulations in human bone marrow in the fol-
lowing sequence: CD341TdT1RAG-l1VpreB
1 cells are DHJH-
rearranged precursors of large, VpreB
1 and VpreB
2, CD342,
TdT2, RAG-12, productively VHDJH-rearranged cells which,
in turn, are precursors of small, VpreB
2, CD342, TdT2,
RAG-11, VHDJH-rearranged cells, which, finally, are fol-
lowed by sIgM1 immature and sIgM1 sIgD1 mature B cells.
Discussion
The analysis of the status of the IgH and L chain gene
loci in single cells of B lineage subpopulations in the bone
marrow of mice has been instrumental in ordering these
subpopulations along a pathway of B lymphocyte develop-
ment (17, 27). This ordering has been guided by the fact
that rearrangements in the Ig loci occur in stepwise fashion,
so that DH segments are rearranged first to JH segments,
then VH segments are rearranged to DHJH segments, and fi-
nally, Vk and Vl segments are rearranged to Jk and Jl seg-
ments, respectively (28). Rearrangements in the kL chain
locus appear often to precede those in the lL chain locus,
and can be terminated by rearrangements into kL chain
gene–deleting elements (29, 30). Stepwise, ordered rear-
rangements in the Ig gene loci are also characteristic for hu-
man B lymphocyte development.
Single-cell PCR analyses of the status of the Ig H and kL
chain loci of B lineage subpopulations in human bone mar-
row performed in this paper allow a similar ordering of hu-
man B lineage subpopulations, characterized by the expres-
sion of CD19, CD10, CD34, VpreB, TdT, RAG-1, and by
their cell cycle status. Comparisons with B cell develop-
ment in the bone marrow of mice allow the following con-
clusions:
(a) Human CD191CD101CD341TdT1RAG-l1 VpreB
1
mH chain2 cycling cells are comparable to murine B2201
CD191TdT1RAG-1/21VpreB
1/l5
1c-kit1,  mH chain2
CD252 cycling pre-B I cells. Both have DHJH-rearranged
Ig H chain loci. Mouse pre-B I cells often have both alleles
DHJH rearranged. Their Ig L chain loci remain in germline
configuration. In analogy to murine pre-B I cells, we will
call them human pre-B I cells.
(b) Human CD191CD101CD342TdT2RAG-12VpreB
1,
mH chain1, pre-B receptor1 cycling cells are comparable
to murine B2201CD191TdT2RAG-12/22c-kit2 CD251
VpreB
1/l5
1  mH chain1 pre-B receptor1 large pre-B II cells.
They are productively VHDJH rearranged in the Ig H chain
locus, while their L chain gene loci remain in germline
configuration. In analogy with mouse pre-B cells, we will
call them large, pre-B receptor1 pre-B II cells.
(c) Human CD191CD101CD342TdT2RAG-12VpreB
2,
mH chain1 pre-B receptor2 cycling cells are comparable
to murine B2201CD191TdT2RAG-12/22c-kit2CD251
VpreB
2/l5
2, pre-B receptor2, mH chain1 sIgM2 large pre-B
II cells. Their H chain locus is productively VHDJH rear-
ranged, while their Ig L chain loci are largely in germline
configuration. In analogy with mouse pre-B II cells, we
will call them large pre-B receptor2 pre-B II cells.
(d) Human CD191CD101CD342TdT2RAG-11VpreB
2,
mH chain1 sIgM2 small resting cells are comparable to mu-
rine  B2201CD191TdT2RAG-11/21c-kit2CD251VpreB
2/
l5
2, mH chain1 small resting pre-B II cells. Both have a
majority of their IgL chain gene loci in VLJL-rearranged
configurations, but do not yet express L chains on their
surface. In analogy with mouse pre-B cells, we will call
them human small resting pre-B II cells.
(e) Human CD191CD101sIgM1 immature B cells are
comparable to murine immature B cells, and human ma-
ture CD191CD102sIgM1sIgD1 B cells are comparable to
murine mature B cells. The RT-PCR analyses of the ex-
pression of the RAG-1 genes in different B lineage sub-
populations of human bone marrow show the same striking
changes that have been observed in mouse B lineage sub-
populations (31). It indicates that the same up- and down-
regulation of the rearrangement machinery that might be
part of the mechanisms effecting allelic exclusion of the H
chain alleles appear to be operative in the human. It appears
that human and mouse B cell subpopulations in the bone
marrow resemble each other, not only in their status of Ig
gene rearrangements of TdT and RAG protein expression
and pre-B receptor expression, but their relative amounts in
the different compartments are also comparable.
The relative proportions of the CD191CD101 B lineage
compartments remain the same throughout life, although
they decrease in frequencies. This suggests that while the
flow from early to late B cell precursors decreases with age,
it continues from the same precursors through the same in-
termediates during life. The relative proportion of the ma-
ture, CD191CD102sIgM1 B cells increases over the CD191
CD101 B lineage cells with age, suggesting that the contri-
bution of recirculating B cells in bone marrow increases
with age. These results confirm earlier findings by Nuñez2227 Ghia et al.
et al. (32), which showed that B cells are continuously gen-
erated through life though the relative frequencies of pre-
cursor B cells in human bone marrow decrease with age.
A few differences between human and mouse B lineage
cells are apparent. First, a small but significant portion of
the large, pre-B receptor expressing and pre-B receptor–
negative human pre-B II cells have kL chain gene loci in
VLJL-rearranged configurations. It cannot be excluded that
this difference is a consequence of the way the bone mar-
row samples are collected. Murine bone marrow cells are
prepared on ice within 15 min after the death of the ani-
mals, while human marrow is aspirated but then kept for
considerable periods of time before staining with specific
antibodies and FACSÒ separation procedures are initiated.
This longer time ex vivo may allow the progression along
the pathways of differentiation of a human precursor B cell
and, hence, allow occasionally L chain rearrangements in
large pre-B II cells, after ex vivo isolation.
Second, VpreB gene expression on mRNA level persists
into a part of the large, pre-B receptor–negative and small,
resting human pre-B II cells, while that is not so in the mu-
rine counterparts. Again, a longer period ex vivo before
staining and FACSÒ might allow cells to change their sur-
face phenotype, downregulate VpreB protein expression but
keep VpreB mRNA intact. Also, it has been observed in hu-
man pre-B cells that stability of surrogate L chain protein
differs in different precursor subpopulations (33). Different
laboratories have developed different mAbs specific for dif-
ferent determinants on surrogate L chain expressed on ei-
ther human or mouse B lineage cells (11, 12, 15). Three
patterns of expressions on different B cell subpopulations of
the marrow have been detected. Lassoued et al. (11) de-
tected surrogate L chain only on CD191CD101TdT2,
pre-B receptor1 (presumably large) cells, which we would
call pre-B II cells. They have concluded that these cells are
the immediate precursors of sIgM1 immature B cells, al-
though they have not offered a placement of the pre-B
receptor2 cytoplasmic mH chain1 precursors, which, ac-
cording to their studies, comprise as many as 80% of all
CD191CD101 B lineage precursors in bone marrow. We
would propose that these pre-B receptor2 cytoplasmic mH
chain1TdT2 precursors are, in majority, VLJL-rearranged
small pre-B II–like cells. They might be the nonproduc-
tively VLJL-rearranged portion of the immature cells and,
hence, one of two direct products of the large, pre-B re-
ceptor–positive and –negative pre-B II cells (Fig. 3, Alter-
native II). This remains to be elucidated by sequencing of
individual VkJk rearrangements in these cells.
It is also possible that they are, at least in part, produc-
tively VLJL rearranged, but not (yet) capable of expressing
Figure 3. Scheme of human B cell differentiation in bone marrow. Two alternative pathways of immature B cell generation are shown (see Discus-
sion). The dotted arrow between small pre-B II and sIgM1 immature B cells in alternative II indicates that the RAG-expressing pre-B II cells continue to
rearrange kL and lL chain loci (21). G, germline configuration. For a comparison to mouse B cell development, see Rolink et al. (36).2228 Immunoglobulin Gene Configurations in Human Lymphocyte B Precursors
kL chain protein. Such VLJL-rearranged, kL chain–negative
cells have been found in the mouse in the case of the 70Z/3
cell line, which is inducible to kL chain expression by stim-
ulation with lipopolysaccharides (34). If this is the case,
they are precursors of the sIgM1 immature B cells and,
hence, in between large pre-B II cells and immature sIgM1
B cells (Fig. 3, Alternative I).
For murine precursors B cells, Winkler et al. (15). have
detected two subpopulations in bone marrow that express
surrogate L chain on the surface (15). One is the pro-/pre-
B I cell population, which expresses surrogate L chain to-
gether with a complex of glycoproteins (35), and the other
is a population of large, cycling pre-B II cells, which is the
progeny of the pre-B I cells and the precursors of large,
pre-B receptor–negative and small, resting pre-B II cells.
Guelpa-Fonlupt et al. (12) have observed the same pattern
of surface expression of surrogate L chain in human bone
marrow. Their antibody, however, also stained sIgM1 im-
mature B cells. The VpreB-specific mAb 688 (16) used in
this paper detects surrogate L chains on human pre-B I and
large pre-B II, but not on small pre-B II and not on imma-
ture sIgM1 B cells, and hence follows the pattern of mu-
rine surrogate L chain expression on the surface. Since our
RT-PCR analyses did not detect VpreB mRNA in imma-
ture sIgM1 B cells, and since our VpreB mRNA–positive
small pre-B II cells did not express detectable levels of VpreB
protein, we see no reason to expect that VpreB expression
could be carried as far as into the sIgM1 immature B cells
population.
The differential expression of CD34, TdT, RAG-1, and
VpreB and differences in cell-cycle status, as well as single
cell PCR analyses of the status of rearrangements in the
IgH and kL chain loci, have allowed us to order cellular
development of B cell precursors in human bone marrow
as it has been done in the mouse. These analyses are ex-
pected to be helpful in an understanding of the cellular
targets of dysregulation leading to autoimmune diseases,
immunodeficiencies, and neoplasia in the human B lym-
phocyte lineage.
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